Mitchell Lawrence Jones
CIK: 0001993292
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PALISADE BIO, INC.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Oct 6, 2026PALI
PALISADE BIO, INC.
Exercise(M)Direct2.6M shares- - Oct 6, 2026PALI
PALISADE BIO, INC.
Tax Payment(F)Direct1M shares at avg. $1.49$1.5M - Jul 7, 2026PALI
PALISADE BIO, INC.
Sale(S)Direct51.9K shares at avg. $2.05$107K - Jul 6, 2026PALI
PALISADE BIO, INC.
Exercise(M)Direct131.2K shares- - Feb 12, 2026PALI
PALISADE BIO, INC.
Sale(S)Direct2K shares at avg. $1.75$3K - Feb 11, 2026PALI
PALISADE BIO, INC.
Exercise(M)Direct8K shares- - Feb 9, 2026PALI
PALISADE BIO, INC.
Award(A)DirectRestricted Stock Units
787K shares- - Oct 6, 2025PALI
PALISADE BIO, INC.
Award(A)DirectRestricted Stock Units
7.7M shares- - Sep 4, 2025PALI
PALISADE BIO, INC.
Award(A)DirectPhantom Units
289K shares- - Feb 11, 2025PALI
PALISADE BIO, INC.
Award(A)DirectStock Option (Right to Buy)
29K shares- - Feb 11, 2025PALI
PALISADE BIO, INC.
Award(A)DirectRestricted Stock Units
24K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 6, 2026 | PALI PALISADE BIO, INC. | Exercise(M) | 2,620,850 | - | $0 | Direct |
| Oct 6, 2026 | PALI PALISADE BIO, INC. | Tax Payment(F) | 1,031,102 | $1.49 | $1,536,342 | Direct |
| Jul 7, 2026 | PALI PALISADE BIO, INC. | Sale(S) | 51,880 | $2.05 | $106,536 | Direct |
| Jul 6, 2026 | PALI PALISADE BIO, INC. | Exercise(M) | 131,167 | - | $0 | Direct |
| Feb 12, 2026 | PALI PALISADE BIO, INC. | Sale(S) | 1,989 | $1.75 | $3,481 | Direct |
| Feb 11, 2026 | PALI PALISADE BIO, INC. | Exercise(M) | 8,000 | - | $0 | Direct |
| Feb 9, 2026 | PALI PALISADE BIO, INC. | Award(A) Restricted Stock Units | 787,000 | - | - | Direct |
| Oct 6, 2025 | PALI PALISADE BIO, INC. | Award(A) Restricted Stock Units | 7,665,800 | - | - | Direct |
| Sep 4, 2025 | PALI PALISADE BIO, INC. | Award(A) Phantom Units | 289,000 | - | - | Direct |
| Feb 11, 2025 | PALI PALISADE BIO, INC. | Award(A) Stock Option (Right to Buy) | 29,000 | - | - | Direct |
| Feb 11, 2025 | PALI PALISADE BIO, INC. | Award(A) Restricted Stock Units | 24,000 | - | - | Direct |
1-11 of 11 transactions
About Jones Mitchell Lawrence
Jones Mitchell Lawrence (SEC CIK 0001993292) files insider reports with the SEC as Officer of PALISADE BIO, INC. (PALI).
Signal8 holds 7 ownership filings by Jones Mitchell Lawrence, all Form 4s, filed between Feb 13, 2025 and Oct 7, 2026. Those filings report 11 transactions, from Feb 11, 2025 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jones Mitchell Lawrence's filings is in DENVER, CO.
Recent filings by Jones Mitchell Lawrence
- Oct 6, 2026: Option exercise of PALI shares (Form 4, code M).
- Oct 6, 2026: Tax withholding of PALI shares (Form 4, code F).
- Jul 7, 2026: Open-market sale of PALI shares (Form 4, code S).
- Jul 6, 2026: Option exercise of PALI shares (Form 4, code M).
- Feb 12, 2026: Open-market sale of PALI shares (Form 4, code S).
Other insiders filing for PALISADE BIO, INC. (PALI)
- Capers Julien E.
- Finley John David, CEO CFO
- Williams Donald Allen, Director
- Baltera Robert Jr., Director
- Wei Binxian, Director
- Chuang Emil, Director